We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Abbott Diagnostics

Abbott Diagnostics provides medical diagnostic instruments, tests, automation and informatics solutions, including cl... read more Featured Products: More products

Download Mobile App




A New Approach for Rapid Detection of Acute Kidney Injury in Children

By LabMedica International staff writers
Posted on 10 Nov 2020
Measurement of a urinary protein combined with a calculated renal angina index was used to identify the early signs of acute kidney injury in children.

Acute kidney injury (AKI), a common complication in pediatric intensive care units (PICU), is associated with longer hospital stay and increased mortality. Diagnosis of AKI depends on identifying elevation of creatinine in the blood. However, creatinine levels rise very slowly after a kidney injury, frequently delaying recognition of AKI.

Searching for a more rapid way to diagnose AKI, investigators at the University of Liverpool (United Kingdom) evaluated the diagnostic and prognostic value of initial and serial concentrations of the protein neutrophil gelatinase-associated lipocalin in urine (uNGAL) and in plasma (pNGAL). Serum creatinine was measured using an enzymatic (Creatininase/Creatinase) method developed by Abbott Diagnostics for use on the Abbott Architect Chemistry Analyzer. uNGAL was measured using the ARCHITECT Urine NGAL assay (Abbott Diagnostics, IL, USA) and pNGAL was measured using a commercial ELISA kit (R&D Systems Inc., Minneapolis, MN, USA).

In addition, a calculated value - the renal angina index (RAI) - was developed as a screening tool to detect those at risk of AKI in intensive care units (ICU). RAI was calculated retrospectively according to previously published protocols, using data obtained upon admission to PICU, and their first serum creatinine measurement on their first day in PICU.

For the current study, 657 children were recruited, with 104 meeting the criteria for severe AKI (15.8%) and 47 (7.2%) requiring renal replacement therapy (RRT). Severe AKI was associated with increased length of stay, hospital acquired infection, and mortality.

Results obtained over the course of the study revealed that the combination of RAI and urinary NGAL on the first day of PICU admission provided an accurate prediction for severe AKI.

Contributing author Dr. Steven J. McWilliam, senior lecturer in pediatric clinical pharmacology at the University of Liverpool, said, "The results of this study are extremely exciting. The renal angina index is a simple calculation that could easily be automatically provided in electronic medical records at PICU admission. NGAL assays compatible with most clinical laboratory analyzers are now widely available, making its real-time measurement in these critically unwell children realistic. We are now in a great position to investigate whether having these results available in real-time in PICUs could lead to reduced rates of AKI in these children, and whether they can be used to effectively target protective strategies to those at high risk of AKI."

The study was published in the October 29, 2020, online edition of the journal PLOS ONE.

Related Links:
University of Liverpool
Abbott Diagnostics
R&D Systems Inc.



Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Respiratory Bacterial Panel
Real Respiratory Bacterial Panel 2
New
Biological Indicator Vials
BI-O.K.
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more

Industry

view channel
Image: Tumor-associated macrophages visualized using the Multiomic LS Assay (Photo courtesy of ACD)

Leica Biosystems and Bio-Techne Expand Spatial Multiomic Collaboration

Bio-Techne Corporation (Minneapolis, MN, USA) has expanded the longstanding partnership between its spatial biology brand, Advanced Cell Diagnostics (ACD, Newark, CA, USA), and Leica Biosystems (Nussloch,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.